Follow-up experiments could examine the contribution of CD4+ T cells, CD8+ T cells, and NK cells to response to therapy in the murine MSS CRC model by blocking the function of each cell population in individual experiments. The gene discussed is CD4; the disease is colorectal carcinoma.